Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918135 | Radiotherapy and Oncology | 2015 | 7 Pages |
Abstract
Despite high applied doses, C12 re-irradiation shows moderate side-effects, response rates even in these heavily pre-treated patients are encouraging and present a good alternative to palliative chemotherapy. Though most local recurrences occur within the high-dose area, further dose escalation should be viewed with caution.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alexandra D. Jensen, Melanie Poulakis, Anna V. Nikoghosyan, Naved Chaudhri, Matthias Uhl, Marc W. Münter, Klaus K. Herfarth, Jürgen Debus,